ResearcherNantong UniversityActive in the last 2 years
Zhiwei Wang
Matched on ORCID iD 0000-0001-8149-8848; OpenAlex author ID A5100449943. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Circ-0030167/IGF2BP1 Induces Mitophagy-Mediated Ferroptosis via HMOX1 mRNA Stabilization in Pancreatic Cancer. Co-author DOI 10.1111/cas.70356↗
- Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker. Co-author DOI 10.1007/s00432-023-05161-8↗
- Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer. Co-author DOI 10.1097/md.0000000000004328↗
- High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival. Co-author DOI 10.1007/s12032-014-0372-2↗
- MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. Last author DOI 10.1186/1471-2407-14-85↗
- Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Last author DOI 10.1016/j.canlet.2013.07.009↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuhua Lu · 4 shared papers, 2013–2026 · strength 0.61
- Paper Circ-0030167/IGF2BP1 Induces Mitophagy-Mediated Ferroptosis via HMOX1 mRNA Stabilization in Pancreatic Cancer. DOI 10.1111/cas.70356↗
- Paper Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker. DOI 10.1007/s00432-023-05161-8↗
- Paper MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. DOI 10.1186/1471-2407-14-85↗
- Qiyang Chen · 2 shared papers, 2023–2026 · strength 0.54
- Xiaohong Li · 1 shared paper, 2026 · strength 0.33
- Xihao Yao · 1 shared paper, 2026 · strength 0.33
- Qun Zhao · 1 shared paper, 2026 · strength 0.33
- Qingsong Guo · 3 shared papers, 2013–2023 · strength 0.27
- Paper Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker. DOI 10.1007/s00432-023-05161-8↗
- Paper MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. DOI 10.1186/1471-2407-14-85↗
- Paper Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. DOI 10.1016/j.canlet.2013.07.009↗
- Jianfei Huang · 2 shared papers, 2015–2016 · strength 0.12
- Xudong Wang · 2 shared papers, 2015–2016 · strength 0.12
- Lei Wang · 2 shared papers, 2013–2014 · strength 0.07
- Mingyan Zhu · 2 shared papers, 2013–2014 · strength 0.07
- Xiaohong Li · 2 shared papers, 2013–2014 · strength 0.07
- Shuijin Lian · 1 shared paper, 2016 · strength 0.06
- Wei Wang · 1 shared paper, 2016 · strength 0.06
- Qingqing Wang · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.